Sue Desmond-Hellmann: A smarter, more precise way to think about public health
Sue Desmond-Hellmann: Um modo mais inteligente e preciso de pensar sobre saúde pública
Sue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person. Full bio
Double-click the English transcript below to play the video.
Theresa Marie.
e Kevin Michael está a sua direita.
and Kevin Michael's on his right.
was picking names.
era escolher nomes.
number seven came along,
on Jennifer Bridget.
por Jennifer Bridget.
ceremonial moment.
momento cerimonial especial.
de seus bebês recém-nascidos
for their new babies
of this special ceremonial time?
esta ocasião cerimonial especial?
bearable without a name.
mais suportável sem um nome.
pode ajudá-los a se sentir
dreaming of the future of that child --
sonhando com o futuro dessa criança,
com um futuro para seu filho
of a future for their child
um mês de idade?
nós simplesmente não sabemos.
an updated pie chart.
recentemente um gráfico atualizado,
menores de cinco anos em todo o mundo".
under five worldwide."
of that pie chart, about 40 percent --
desse gráfico, cerca de 40%,
tem idade inferior a um mês.
is less than one month old.
"We have no idea."
"Não temos a menor ideia".
what you can't define.
o que não consegue definir.
the dreams of those parents
para devolver os sonhos daqueles pais
about a new approach,
sobre uma nova abordagem,
know why babies are dying,
por que os bebês estão morrendo,
a transformar completamente
from a very special place.
vem de um lugar muito especial.
an oncologist.
ajudar as pessoas a se sentirem melhor.
to help people feel better.
as faziam sentir pior.
made them feel worse.
being driven to my clinic
sendo levadas para a minha clínica
into my exam room by their mothers.
até a minha sala de exames por suas mães.
do tratamento que eu tinha dado a elas.
in the war on cancer,
na luta contra o câncer,
couldn't differentiate
não conseguiam diferenciar
que queríamos combater
that we wanted to hit hard
que queríamos preservar.
that we wanted to preserve.
all very familiar with --
que todos conhecemos,
uma ameaça constante de infecções,
so infection was a constant threat --
to the biotechnology industry.
para a indústria de biotecnologia.
para pacientes com câncer de mama,
for breast cancer patients
na distinção entre as células saudáveis
of telling the healthy cells
o câncer de mama HER2-positivo,
HER2-positive breast cancer,
form of breast cancer.
de mama mais assustador.
hit hard the cancer cells,
atacar células cancerosas com eficiência,
gentle on the normal cells.
agindo de forma mais branda.
todas essas ferramentas:
gene sequencing and more --
sequenciamento genético e muito mais,
variedade de doenças.
no momento certo.
revolutionized cancer therapy.
revolucionou o tratamento do câncer.
e melhor de abordar as doenças
better way to tackle diseases
expensive medicines like Herceptin
medicamentos caros, como Herceptin,
desta meta precisa para indivíduos
targeting for individuals
you're thinking, "She's crazy.
estão pensando: "Ela é louca.
de uma maneira limitada,
a fazer uma grande diferença.
to make a big difference.
como oncologista.
as a cancer doctor.
who trained in San Francisco in the '80s,
medicina em São Francisco nos anos 80,
no tratamento da AIDS.
a terrible global challenge.
um desafio global terrível.
are living with HIV.
de mulheres são soropositivas.
become pregnant,
na ausência de tratamento,
until the age of two.
até os dois anos de idade.
can virtually guarantee
antirretroviral pode praticamente garantir
o vírus para o bebê.
the virus to the baby.
kind of like that blast of chemo,
como a da rajada de quimioterapia,
todas as grávidas no mundo.
every pregnant woman in the world.
where HIV rates are the highest.
em que as taxas de HIV são mais elevadas.
in sub-Saharan Africa
na África subsaariana
nas quais as taxas são mais elevadas.
where rates are highest.
para um problema de saúde pública
to a public health problem
dos países em desenvolvimento
in certain areas in the developing world
pode mudar as coisas em grande escala.
can change things on a big scale.
elements of precision public health:
importantes da saúde pública de precisão:
to the 2.6 million babies
sobre os 2,6 milhões de bebês
um mês de idade.
nós simplesmente não sabemos.
the causes of infant mortality
da mortalidade infantil
mantendo conversas com a mãe.
with the highest infant mortality
who has just lost her child,
a uma mãe que acaba de perder seu filho:
Ele estava com febre?"
Did they have a fever?"
after the baby has died.
de o bebê ter morrido.
in the shoes of that mom.
excruciating conversation.
there was a fever or vomiting,
que houve febre ou vômitos,
that knowledge,
naquela comunidade
a precision public health approach?
de saúde pública de precisão?
que em certas áreas da África
devido a uma infecção bacteriana
because of a bacterial infection
mom has a seven times higher chance
seu próximo bebê é sete vezes maior.
we can prevent that death
podemos prevenir aquela morte
e seguro como a penicilina.
and safe as penicillin.
porque então saberemos.
the right interventions
podemos trazer as intervenções certas
in the right places
and with these interventions
de saúde pública de precisão
a alcançar nossa meta de 15 anos.
our 15-year goal.
into a million babies' lives saved
em um milhão de bebês salvos
to public health --
para a saúde pública,
a desnutrição de forma mais eficaz?
tackle malnutrition?
cervical cancer in women?
o câncer cervical em mulheres?
in two different worlds,
by public health professionals.
por profissionais de saúde pública.
é juntar estes dois mundos.
about precision public health
é que a saúde pública de precisão
talent and tools --
de maneiras que eu nunca imaginei
in ways I never imagined
that kind of talent and tools
esses talentos e ferramentas
morram nos países pobres.
the confidence
no momento em que ele nascesse,
the moment that child is born,
will be measured in decades,
será medida em décadas,
ABOUT THE SPEAKER
Sue Desmond-Hellmann - CEO, Gates FoundationSue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person.
Why you should listen
As CEO of the Bill & Melinda Gates Foundation, Sue Desmond-Hellmann leads the organization's vision for a world where every person has the opportunity to live a healthy, productive life. Drawing on her diverse experience as scientist, physician and business executive, she oversees a variety of missions focused on eradicating disease, poverty and inequity. She leads 1,400 people, across four continents, working in more than 100 countries to help more children and young people survive and thrive, combat infectious diseases that hit the poorest hardest, and empower people -- particularly women and girls -- to transform their lives.
Trained as an oncologist, Dr. Desmond-Hellmann spent 14 years at biotech firm Genentech, developing a number of breakthrough medicines, including two of the first gene-targeted therapies for cancer, Avastin and Herceptin. In November 2009, Forbes magazine named her one of the world's seven most "powerful innovators," calling her "a hero to legions of cancer patients." Her time at Genentech put her at the forefront of the precision medicine revolution, and in her current role she champions a similar approach to global development: precision public health -- getting the right interventions, to the right populations, in the right places, to save lives.
Immediately prior to joining the foundation in 2014, Dr. Desmond-Hellmann was the first female chancellor of the University of California at San Francisco (UCSF), overseeing all aspects of the university and medical center's strategy and operations. It was her second stint at UCSF, having completed her clinical training there in the 1980s. She moved to Uganda in 1989 to work on HIV/AIDS and cancer, which she credits as a turning point in her career. "It was so profound to recognize ... that all the learning I had done to become a doctor didn't matter at all if I didn’t make a contribution," she said.
Dr. Desmond-Hellmann is the recipient of numerous honors and awards. She was listed among Fortune magazine's "50 most powerful women in business" for seven years. In 2010, she was inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine. She serves on the boards of directors at Facebook Inc. and the Procter & Gamble Company.
Sue Desmond-Hellmann | Speaker | TED.com